Antimicrobial Susceptibility Testing Market Analysis and Global Forecast 2023-2033
¥8,847.35 – ¥35,134.80Price range: ¥8,847.35 through ¥35,134.80
Antimicrobial Susceptibility Testing Market Research Report: Information By Product Type (Instruments, Consumables & Accessories, Services & Software Others), By Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), and by Region — Forecast till 2033
Page: 168
Antimicrobial Susceptibility Testing Market Overview
The Antimicrobial Susceptibility Testing Market Size is expected to reach USD 8.41 Billion by 2033. The Antimicrobial Susceptibility Testing industry size accounted for USD 3.62 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2033. The antimicrobial susceptibility testing market involves diagnostic technologies used to determine the effectiveness of antibiotics and other antimicrobial agents against pathogens. This market is driven by the increasing prevalence of infectious diseases and the rise of antibiotic-resistant strains. Key segments include disc diffusion, broth microdilution, and automated systems. The market encompasses various applications in hospitals, diagnostic laboratories, and research institutions. Growth is supported by advancements in technology, increasing awareness of antimicrobial stewardship, and rising healthcare expenditures. Major players include companies specializing in diagnostic instruments and reagents.
Global Antimicrobial Susceptibility Testing Market Synopsis
The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the antimicrobial susceptibility testing market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.
Antimicrobial Susceptibility Testing Market Dynamics
The major factors that have impacted the growth of Antimicrobial Susceptibility Testing are as follows:
Drivers:
Ø Technological Advancements
Innovations in diagnostic technologies, such as automated AST systems and high-throughput screening methods, have improved the accuracy and efficiency of susceptibility testing. These advancements drive market growth by providing faster results and more comprehensive data.
Restraint:
- High Costs of Advanced Technologies
The cost of advanced AST technologies, such as automated systems and high-throughput platforms, can be prohibitively high for many healthcare facilities, especially in developing regions. This limits their accessibility and adoption, constraining market growth.
Opportunity:
⮚     Increased Government and Public Health Initiatives
Governments and international organizations are intensifying efforts to combat antimicrobial resistance through various initiatives and funding programs. Support for research, development, and deployment of AST technologies can drive market growth and innovation.
Antimicrobial Susceptibility Testing Segment Overview
By Product Type
Based on Product Type, the market is segmented based on Instruments, Consumables & Accessories, Services & Software Others. clinical diagnostics dominates due to its critical role in guiding effective treatment decisions for infectious diseases in healthcare settings.
By Application
Based on Applications, the market has been divided into the Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others. clinical diagnostics dominates due to its critical role in guiding effective treatment decisions for infectious diseases in healthcare settings.
Global Antimicrobial Susceptibility Testing Market Regional Analysis
Based on region, the global Antimicrobial Susceptibility Testing market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. North America is projected to dominate the use of the Antimicrobial Susceptibility Testing market followed by the Asia-Pacific and Europe regions.
Antimicrobial Susceptibility Testing North America Market
North America holds a dominant position in the Antimicrobial Susceptibility Testing Market. In North America, the antimicrobial susceptibility testing (AST) market is driven by advanced healthcare infrastructure, high prevalence of infectious diseases, and robust research and development activities. The region benefits from significant investments in diagnostic technologies and a strong emphasis on combating antimicrobial resistance. The presence of major diagnostic companies and high healthcare expenditure further supports market growth.
Antimicrobial Susceptibility Testing Asia-Pacific Market
The Asia-Pacific region has indeed emerged as the fastest-growing market for the Antimicrobial Susceptibility Testing industry. In the Asia-Pacific region, the antimicrobial susceptibility testing (AST) market is growing rapidly due to rising healthcare investments, increasing incidences of infectious diseases, and expanding healthcare infrastructure. The region’s large population base and high burden of antimicrobial resistance drive demand for effective AST solutions. Additionally, government initiatives and growing awareness of antimicrobial stewardship contribute to market growth.
Competitive Landscape
The global Antimicrobial Susceptibility Testing market is highly competitive, with numerous players offering a wide range of software solutions. The competitive landscape is characterized by the presence of established companies, as well as emerging startups and niche players. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as product launches, and strategic alliances.
Prominent Players:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioMérieux S.A.
- Becton
- MERLIN Diagnostika GmbH
- Accelerate Diagnostics, Inc.
- Alifax S.r.l.
- Creative Diagnostics
- SYNBIOSIS
Key Development
In September 2022, Thermo Fisher Scientific Inc. launched the Thermo Scientificâ„¢ Sensititreâ„¢ 8-Panel AST System, enhancing antimicrobial susceptibility testing with a comprehensive, automated solution for faster and more accurate results.
Scope of the Report
Global Antimicrobial Susceptibility Testing Market, by Product
- Instruments
- Consumables & Accessories
- Services & Software
- Others
 Global Antimicrobial Susceptibility Testing Market, by Application
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
 Global Antimicrobial Susceptibility Testing Market, by Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Benelux
- Nordic
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Indonesia
- Austalia
- Malaysia
- India
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of Middle East & Africa
| Parameters | Indicators |
|---|---|
| Market Size | 2033: $8.41 Billion |
| CAGR | 7.5% CAGR (2023-2033) |
| Base year | 2022 |
| Forecast Period | 2023-2033 |
| Historical Data | 2021 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Key Segmentations | Product Type, Application |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, Middle East, Africa |
| Key Vendors | Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., BioMérieux S.A., Becton, MERLIN Diagnostika GmbH, Accelerate Diagnostics, Inc., Alifax S.r.l., Creative Diagnostics, SYNBIOSIS |
| Key Market Opportunities | • The rise of e-commerce |
| Key Market Drivers | • Technological Advancements • Increasing Urbanization |
REPORT CONTENT BRIEF:
- High-level analysis of the current and future Antimicrobial Susceptibility Testing market trends and opportunities
- Detailed analysis of current market drivers, restraining factors, and opportunities in the future
- Antimicrobial Susceptibility Testing market historical market size for the year 2021, and forecast from 2023 to 2033
- Antimicrobial Susceptibility Testing market share analysis at each product level
- Competitor analysis with detailed insight into its product segment, Government & Defense strength, and strategies adopted.
- Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
- To identify and understand the various factors involved in the global Antimicrobial Susceptibility Testing market affected by the pandemic
- To provide a detailed insight into the major companies operating in the market. The profiling will include the Government & Defense health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.
Press Release

Global Pharmaceutical Manufacturing Market to Reach $1.38 Trillion by 2035 with 7.35% CAGR, New Research Shows

The Global Mammography Market Is Estimated To Record a CAGR of Around 10.29% During The Forecast Period

Glue Stick Market to Reach USD 2.35 Billion by 2034

Podiatry Service Market to Reach USD 11.88 Billion by 2034

Microfluidics Technology Market to Reach USD 32.58 Billion by 2034

Ferric Chloride Market to Reach USD 10.65 Billion by 2034

Family Practice EMR Software Market to Reach USD 21.52 Billion by 2034

Electric Hairbrush Market to Reach USD 15.95 Billion by 2034

Daily Bamboo Products Market to Reach USD 143.52 Billion by 2034

Cross-border E-commerce Logistics Market to Reach USD 112.65 Billion by 2034
Frequently Asked Questions (FAQ)
What is the study period of this market?
The study period of the global Antimicrobial Susceptibility Testing market is 2021- 2033
What is the growth rate of the global Antimicrobial Susceptibility Testing market?
The global Antimicrobial Susceptibility Testing market is growing at a CAGR of 7.5% over the next 10 years
Which region has the highest growth rate in the market of Antimicrobial Susceptibility Testing?
Asia Pacific is expected to register the highest CAGR during 2023-2033
Which region has the largest share of the global Antimicrobial Susceptibility Testing market?
North America holds the largest share in 2022
Who are the key players in the global Antimicrobial Susceptibility Testing market?
Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., BioMérieux S.A., Becton, MERLIN Diagnostika GmbH, Accelerate Diagnostics, Inc., Alifax S.r.l., Creative Diagnostics, and SYNBIOSIS are the major companies operating in the market
Do you offer Post Sale Support?
Yes, we offer 16 hours of analyst support to solve the queries
Do you sell particular sections of a report?
Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.
Table of Content
Chapter 1. Executive Summary Chapter 2. Scope Of The Study 2.1. Market Definition 2.2. Scope Of The Study 2.2.1. Objectives of Report Chapter 3. Evolve BI Methodology Chapter 4. Market Insights and Trends 4.1. Supply/ Value Chain Analysis 4.2. Porter’s Five Forces Analysis 4.2.1. Threat Of New Entrants 4.2.2. Bargaining Power Of Buyers 4.2.3. Bargaining Power Of Suppliers 4.2.4. Threat Of Substitutes 4.2.5. Industry Rivalry 4.3. Impact of COVID-19 on Antimicrobial Susceptibility Testing Market 4.3.1. Impact on Market Size 4.3.2. End User Trend, Preferences and Budget Impact 4.3.3. Regulatory Framework/Government Policies 4.3.4. Key Players Strategy to Tackle Negative Impact 4.3.5. Opportunity Window Chapter 5. Market Dynamics 5.1. Introduction 5.2. DRO Analysis 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities Chapter 6. Global Antimicrobial Susceptibility Testing Market, By Product Type 6.1. Introduction 6.2. Instruments 6.3. Consumables & Accessories 6.3. Services & Software Chapter 7. Global Antimicrobial Susceptibility Testing Market, By Application 7.1. Introduction 7.2. Clinical Diagnostics 7.3. Drug Discovery and Development 7.4. Epidemiology Chapter 8. Global Antimicrobial Susceptibility Testing Market, By Region 8.1. Introduction 8.2. North America 8.2.1. Introduction 8.2.2. Driving Factors, Opportunity Analyzed and Key Trends 8.2.3. Market Size and Forecast, By Country, 2020 - 2028 8.2.4. Market Size and Forecast, By Product Type, 2020 - 2028 8.2.5. Market Size and Forecast, By Application, 2020 – 2026 8.2.6. US 8.2.6.1. Introduction 8.2.6.2. Driving Factors, Opportunity Analyzed and Key Trends 8.2.6.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.2.6.4. Market Size and Forecast, By Application, 2020 - 2028 8.2.7. Canada 8.2.7.1. Introduction 8.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends 8.2.7.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.2.7.4. Market Size and Forecast, By Application, 2020 - 2028 8.3. Europe 8.3.1. Introduction 8.3.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.3. Market Size and Forecast, By Country, 2020 - 2028 8.3.4. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.5. Market Size and Forecast, By Application, 2020 – 2026 8.3.6. Germany 8.3.6.1. Introduction 8.3.6.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.6.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.6.4. Market Size and Forecast, By Application, 2020 - 2028 8.3.7. France 8.3.7.1. Introduction 8.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.7.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.7.4. Market Size and Forecast, By Application, 2020 - 2028 8.3.8. UK 8.3.8.1. Introduction 8.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.8.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.8.4. Market Size and Forecast, By Application, 2020 - 2028 8.3.9. Italy 8.3.9.1. Introduction 8.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.9.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.9.4. Market Size and Forecast, By Application, 2020 - 2028 8.3.10. Rest Of Europe 8.3.10.1. Introduction 8.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends 8.3.10.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.3.10.4. Market Size and Forecast, By Application, 2020 - 2028 8.4. Asia-Pacific 8.4.1. Introduction 8.4.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.3. Market Size and Forecast, By Country, 2020 - 2028 8.4.4. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.5. Market Size and Forecast, By Application, 2020 - 2028 8.4.6. China 8.4.6.1. Introduction 8.4.6.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.6.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.6.4. Market Size and Forecast, By Application, 2020 - 2028 8.4.7. India 8.4.7.1. Introduction 8.4.7.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.7.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.7.4. Market Size and Forecast, By Application, 2020 - 2028 8.4.8. Japan 8.4.8.1. Introduction 8.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.8.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.8.4. Market Size and Forecast, By Application, 2020 - 2028 8.4.9. South Korea 8.4.9.1. Introduction 8.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.9.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.9.4. Market Size and Forecast, By Application, 2020 - 2028 8.4.10. Rest Of Asia-Pacific 8.4.10.1. Introduction 8.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends 8.4.10.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.4.10.4. Market Size and Forecast, By Application, 2020 - 2028 8.5. Rest Of The World (RoW) 8.5.1. Introduction 8.5.2. Driving Factors, Opportunity Analyzed and Key Trends 8.5.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.5.4. Market Size and Forecast, By Application, 2020 - 2028 8.5.5. Market Size and Forecast, By Region, 2020 - 2028 8.5.6. South America 8.5.6.1. Introduction 8.5.6.2. Driving Factors, Opportunity Analyzed and Key Trends 8.5.6.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.5.6.4. Market Size and Forecast, By Application, 2020 - 2028 8.5.7. Middle East and Africa 8.5.7.1. Introduction 8.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends 8.5.7.3. Market Size and Forecast, By Product Type, 2020 - 2028 8.5.7.4. Market Size and Forecast, By Application, 2020 - 2028 Chapter 9. Competitive Landscape 9.1. Introduction 9.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020 Chapter 10. Company Profiles 10.1. Thermo Fisher Scientific Inc. 10.1.1. Business Overview 10.1.2. Financial Analysis 10.1.3. Product Portfolio 10.1.4. Recent Development and Strategies Adopted 10.1.5. SWOT Analysis 10.2. Merck KGaA 10.2.1. Business Overview 10.2.2. Financial Analysis 10.2.3. Product Portfolio 10.2.4. Recent Development and Strategies Adopted 10.2.5. SWOT Analysis 10.3. Bio-Rad Laboratories, Inc. 10.3.1. Business Overview 10.3.2. Financial Analysis 10.3.3. Product Portfolio 10.3.4. Recent Development and Strategies Adopted 10.3.5. SWOT Analysis 10.4. bioMérieux S.A. 10.4.1. Business Overview 10.4.2. Financial Analysis 10.4.3. Product Portfolio 10.4.4. Recent Development and Strategies Adopted 10.4.5. SWOT Analysis 10.5. Becton 10.5.1. Business Overview 10.5.2. Financial Analysis 10.5.3. Product Portfolio 10.5.4. Recent Development and Strategies Adopted 10.5.5. SWOT Analysis 10.6. MERLIN Diagnostika GmbH 10.6.1. Business Overview 10.6.2. Financial Analysis 10.6.3. Product Portfolio 10.6.4. Recent Development and Strategies Adopted 10.6.5. SWOT Analysis 10.7. Accelerate Diagnostics, Inc. 10.7.1. Business Overview 10.7.2. Financial Analysis 10.7.3. Product Portfolio 10.7.4. Recent Development and Strategies Adopted 10.7.5. SWOT Analysis 10.8. Alifax S.r.l. 10.8.1. Business Overview 10.8.2. Financial Analysis 10.8.3. Product Portfolio 10.8.4. Recent Development and Strategies Adopted 10.8.5. SWOT Analysis 10.9. Creative Diagnostics 10.9.1. Business Overview 10.9.2. Financial Analysis 10.9.3. Product Portfolio 10.9.4. Recent Development and Strategies Adopted 10.9.5. SWOT Analysis 10.10. Synbiosis 10.10.1. Business Overview 10.10.2. Financial Analysis 10.10.3. Product Portfolio 10.10.4. Recent Development and Strategies Adopted 10.10.5. SWOT Analysis Chapter 11. Key Takeaways
Connect to Analyst
Research Methodology





